Biotech · Private company
Wayshine Biopharm, Inc.
Track this companyFree. Adds Wayshine Biopharm, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- WSD0922-FU Tablets, Dose level APhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- WSD0922-FU Tablets, Dose level BPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung CancerPHASE2 · RECRUITING · started Aug 18, 2025ClinicalTrials.gov NCT06868485 · fetched Nov 12, 2026